243 related articles for article (PubMed ID: 36964445)
1. Risk-prediction models for intravenous immunoglobulin resistance in Kawasaki disease: Risk-of-Bias Assessment using PROBAST.
Wang S; Huang H; Hou M; Xu Q; Qian W; Tang Y; Li X; Qian G; Ma J; Zheng Y; Shen Y; Lv H
Pediatr Res; 2023 Sep; 94(3):1125-1135. PubMed ID: 36964445
[TBL] [Abstract][Full Text] [Related]
2. Prediction of intravenous immunoglobulin resistance in Kawasaki disease in children.
Wu S; Liao Y; Sun Y; Zhang CY; Zhang QY; Yan H; Qi JG; Liu XQ; Chen YH; Wang YL; Li XY; Jin HF; Du JB
World J Pediatr; 2020 Dec; 16(6):607-613. PubMed ID: 32232677
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Nomogram to predict risk of resistance to intravenous immunoglobulin in children hospitalized with Kawasaki disease in Eastern China.
Huang H; Jiang J; Shi X; Qin J; Dong J; Xu L; Huang C; Liu Y; Zheng Y; Hou M; Shen Q; Zeng B; Qian G; Yang F; Lv H
Ann Med; 2022 Dec; 54(1):442-453. PubMed ID: 35099338
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of laboratory predictors for intravenous immunoglobulin resistance and coronary artery aneurysm in Kawasaki Disease before and after therapy.
Liu J; Ye B; Su D; Qin S; Zhao W; Pang Y
Clin Rheumatol; 2023 Jan; 42(1):167-177. PubMed ID: 36129563
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein to albumin ratio as a prognostic tool for predicting intravenous immunoglobulin resistance in children with kawasaki disease: a systematic review of cohort studies.
Liu J; Chen X; Yang M; Shen F; Zhu F; Jin J; Teng Y
Pediatr Rheumatol Online J; 2024 Apr; 22(1):42. PubMed ID: 38610057
[TBL] [Abstract][Full Text] [Related]
7. Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease.
Lu Y; Chen T; Wen Y; Si F; Wu X; Yang Y
BMC Pediatr; 2021 Sep; 21(1):406. PubMed ID: 34530763
[TBL] [Abstract][Full Text] [Related]
8. Predictors of intravenous immunoglobulin-resistant Kawasaki disease in children: a meta-analysis of 4442 cases.
Li X; Chen Y; Tang Y; Ding Y; Xu Q; Sun L; Qian W; Qian G; Qin L; Lv H
Eur J Pediatr; 2018 Aug; 177(8):1279-1292. PubMed ID: 29948255
[TBL] [Abstract][Full Text] [Related]
9. The expression of autophagy markers in IVIG-resistant Kawasaki disease and the establishment of prediction model.
Zhou Y; Wu Y; Yuan C; Yin W; Wang B; Ding Y
BMC Pediatr; 2023 Dec; 23(1):642. PubMed ID: 38114939
[TBL] [Abstract][Full Text] [Related]
10. [Expression of interleukin-17A in serum of children with intravenous immunoglobulin-resistant Kawasaki disease and its clinical significance].
Li SY; Ding Y
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Mar; 25(3):244-249. PubMed ID: 36946157
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
Sato S; Kawashima H; Kashiwagi Y; Hoshika A
Int J Rheum Dis; 2013 Apr; 16(2):168-72. PubMed ID: 23773640
[TBL] [Abstract][Full Text] [Related]
12. Prediction of intravenous immunoglobulin resistance in patients with Kawasaki disease according to the duration of illness prior to treatment.
Ha KS; Lee J; Lee KC
Eur J Pediatr; 2020 Feb; 179(2):257-264. PubMed ID: 31713683
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of C-reactive protein to albumin ratio as a biomarker for initial and repeated intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients: a prospective cohort study.
Liu X; Wang L; Zhou K; Shao S; Hua Y; Wu M; Liu L; Wang C
Pediatr Rheumatol Online J; 2021 Mar; 19(1):24. PubMed ID: 33712036
[TBL] [Abstract][Full Text] [Related]
14. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
[TBL] [Abstract][Full Text] [Related]
15. Predictors and a novel predictive model for intravascular immunoglobulin resistance in Kawasaki disease.
Wang J; Huang X; Guo D
Ital J Pediatr; 2023 Sep; 49(1):126. PubMed ID: 37749617
[TBL] [Abstract][Full Text] [Related]
16. Development of an immunoinflammatory indicator-related dynamic nomogram based on machine learning for the prediction of intravenous immunoglobulin-resistant Kawasaki disease patients.
Wang Y; Cao Y; Li Y; Zhu F; Yuan M; Xu J; Ma X; Li J
Int Immunopharmacol; 2024 Jun; 134():112194. PubMed ID: 38703570
[TBL] [Abstract][Full Text] [Related]
17. Association between serum miR-221-3p and intravenous immunoglobulin resistance in children with Kawasaki disease.
Jing F; Weng H; Pei Q; Zhang J; Liu R; Yi Q
Clin Exp Med; 2022 Nov; 22(4):621-628. PubMed ID: 35039938
[TBL] [Abstract][Full Text] [Related]
18. Prediction Model Risk-of-Bias Assessment Tool for coronary artery lesions in Kawasaki disease.
Huang H; Dong J; Wang S; Shen Y; Zheng Y; Jiang J; Zeng B; Li X; Yang F; Ma S; He Y; Lin F; Chen C; Chen Q; Lv H
Front Cardiovasc Med; 2022; 9():1014067. PubMed ID: 36312287
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of albumin for intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients.
Zhang R; Shuai S; Zhang H; Cai J; Cui N; Tang M; Xing S; Gao Y; Liu X; Yang X
Ital J Pediatr; 2023 Jun; 49(1):78. PubMed ID: 37357258
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease.
Ye Q; Gong FQ; Shang SQ; Hu J
Clin Immunol; 2016 Oct; 171():25-31. PubMed ID: 27519954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
